Literature DB >> 24972820

Delayed diagnosis in ALS: the problem continues.

Hipolito Nzwalo1, Daisy de Abreu2, Michael Swash3, Susana Pinto4, Mamede de Carvalho5.   

Abstract

We studied the limitations to early diagnosis in amyotrophic lateral sclerosis (ALS). The diagnostic process was assessed in 120 consecutive patients, including onset, interval to diagnosis, investigations, specialist assessment and pre-diagnostic management. Times from onset to first consultation (T1), second consultation (T2) and diagnosis (TD) were considered. Predictors of diagnostic delay were determined by multivariate logistic regression, adjusted for gender, age, clinical manifestations, and specialism of the first and second consultants. There were 101 consecutive ALS patients with complete datasets (69% men; median age at diagnosis 61.5 years). The mean TD and median TD were respectively 10.1 and 9.5 months. In 55%, the first consultant was a general practitioner (GP), in 16% a neurologist and in 14% an orthopedist. The diagnosis of ALS was made by non-neurologists in 9 patients. The odds of delayed diagnosis (≥ 12 months) were higher (1.56; 0.19-12.56) in younger patients (≤ 45 years) (p<0.05). Female gender (0.56; 0.29-1.70) and bulbar-onset (0.56; 0.29-1.70) were independently associated with earlier diagnosis (p<0.05). Assessment by a neurologist at the first (0.32; 0.19-2.46) or second consultation (0.87; 0.21-1.21) was associated with a shorter diagnosis time (< 12 months) (p<0.05). We conclude that diagnostic delay mainly resulted from delayed referral from non-neurologist physicians to a neurologist. Moreover, incomplete neurophysiological investigation had a relevant impact.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Diagnosis delay; General practitioner; Motor neuron disease; Neurologist

Mesh:

Year:  2014        PMID: 24972820     DOI: 10.1016/j.jns.2014.06.003

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Depression in amyotrophic lateral sclerosis.

Authors:  Elin Roos; Daniela Mariosa; Caroline Ingre; Cecilia Lundholm; Karin Wirdefeldt; Per M Roos; Fang Fang
Journal:  Neurology       Date:  2016-04-22       Impact factor: 9.910

2.  Radial diffusivity as an imaging biomarker for early diagnosis of non-demented amyotrophic lateral sclerosis.

Authors:  Yifang Bao; Liqin Yang; Yan Chen; Biyun Zhang; Haiqing Li; Weijun Tang; Daoying Geng; Yuxin Li
Journal:  Eur Radiol       Date:  2018-06-08       Impact factor: 5.315

Review 3.  MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.

Authors:  Frank Cloutier; Alier Marrero; Colleen O'Connell; Pier Morin
Journal:  J Mol Neurosci       Date:  2014-11-30       Impact factor: 3.444

4.  Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.

Authors:  Arianna Sala; Leonardo Iaccarino; Piercarlo Fania; Emilia G Vanoli; Federico Fallanca; Caterina Pagnini; Chiara Cerami; Andrea Calvo; Antonio Canosa; Marco Pagani; Adriano Chiò; Angelina Cistaro; Daniela Perani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-07       Impact factor: 9.236

5.  The diagnostic utility of patient-report and speech-language pathologists' ratings for detecting the early onset of bulbar symptoms due to ALS.

Authors:  Kristen M Allison; Yana Yunusova; Thomas F Campbell; Jun Wang; James D Berry; Jordan R Green
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-03-29       Impact factor: 4.092

Review 6.  Role of Magnetic Resonance Imaging in Diagnosis of Motor Neuron Disease: Literature Review and Two Case Illustrations.

Authors:  Khalid Sawalha; Eduardo Gonzalez-Toledo; Omar Hussein
Journal:  Perm J       Date:  2019

7.  Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).

Authors:  Rachel Waller; Emily F Goodall; Marta Milo; Jonathan Cooper-Knock; Marc Da Costa; Esther Hobson; Mbombe Kazoka; Helen Wollff; Paul R Heath; Pamela J Shaw; Janine Kirby
Journal:  Neurobiol Aging       Date:  2017-04-01       Impact factor: 4.673

8.  Dropped head and man-in-barrel syndrome in amyotrophic lateral sclerosis.

Authors:  Rui Almeida; Ana Catarina Felix; Ana Luísa André; Hipólito Nzwalo
Journal:  Oxf Med Case Reports       Date:  2017-04-04

9.  Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners.

Authors:  Martin Matharan; Stéphane Mathis; Sarah Bonabaud; Louis Carla; Antoine Soulages; Gwendal Le Masson
Journal:  Neurol Res Int       Date:  2020-05-11

Review 10.  The utility of electrodiagnostic tests for the assessment of medically unexplained weakness and sensory deficit.

Authors:  Josep Valls-Solé
Journal:  Clin Neurophysiol Pract       Date:  2016-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.